| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |